The Digital Health Applications (DiGA) framework, established under the Digital Healthcare Act (DVG) in 2019, allows certain digital health apps to be prescribed by physicians and reimbursed by statutory health insurance.  The …

In the dynamic realm of healthcare, digital health solutions are rapidly emerging as pivotal tools, particularly for managing chronic conditions. Unlike traditional pharmaceutical therapies, digital health applications (apps) offer scalable, flexible and …

Sepsis remains one of the most critical challenges in emergency medicine, often leading to high mortality rates due to its rapid progression and the necessity for swift intervention. Traditional diagnostic methods, whilst …

In the rapidly evolving realm of digital health, ensuring that innovative technologies are both safe and effective is paramount. For digital health manufacturers, understanding and navigating the assessment frameworks that govern market …

As we mark Breast Cancer Awareness Month, it’s vital to highlight the progress being made in the tools we use to diagnose and treat this complex disease. Among the latest innovations is the MammaTyper® …

In Spain, getting in vitro diagnostics (IVDs) reimbursed involves navigating distinct pathways, each with its focus and requirements. The three primary systems are theSpanish Catalogue of Health Products, the Common Portfolio (Cartera …

GSK is taking a bold step forward in the fight against immune-related diseases by investing £50 million into a new five-year collaboration with the University of Cambridge and Cambridge University Hospitals. Dubbed the Cambridge-GSK Translational Immunology Collaboration …

Roche Diagnostics has reached a major milestone as the World Health Organisation (WHO) has granted pre-qualification to its cobas® HPV test for use on the cobas 5800, 6800, and 8800 systems, including for self-collected samples. …